Relief Therapeutics Holding SA Stock price
Equities
RLF
CH1251125998
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 CHF | -2.82% | +6.15% | -30.65% |
Mar. 22 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Mar. 22 | Sector Update: Health Care | MT |
Sales 2021 | 3.32 3 | Sales 2022 | 6.08 5.49 | Capitalization | 132M 119M |
---|---|---|---|---|---|
Net income 2021 | -34M -30.72M | Net income 2022 | -50M -45.17M | EV / Sales 2021 | 70,411,981 x |
Net cash position 2021 | 40.5M 36.59M | Net cash position 2022 | 14.89M 13.46M | EV / Sales 2022 | 19,251,190 x |
P/E ratio 2021 |
-6.44
x | P/E ratio 2022 |
-2.5
x | Employees | 69 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.87% |
1 day | -2.82% | ||
1 week | +6.15% | ||
Current month | -9.21% | ||
1 month | -13.21% | ||
3 months | -25.41% | ||
6 months | -36.70% | ||
Current year | -30.65% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | - | 22-01-27 |
Jeremy Meinen
DFI | Director of Finance/CFO | - | - |
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Paolo Galfetti
COO | Chief Operating Officer | - | 21-05-26 |
Thomas Plitz
BRD | Director/Board Member | 56 | 20-12-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 1.33 | -3.62% | 23,029 |
24-03-26 | 1.38 | -2.82% | 11,941 |
24-03-25 | 1.42 | 0.00% | 15,775 |
24-03-22 | 1.42 | +8.40% | 42,656 |
24-03-21 | 1.31 | +0.77% | 6,347 |
End-of-day quote Swiss Exchange, March 25, 2024
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.65% | 18.42M | |
+9.16% | 45.97B | |
+53.75% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |